_PRIVATE_LIMITED.webp)
Zorg Life Sciences (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue 111.56%
(FY 2022)
- Profit 29.14%
(FY 2022)
- Ebitda 49.92%
(FY 2022)
- Net Worth 112.96%
(FY 2022)
- Total Assets 45.27%
(FY 2022)
About Zorg Life Sciences (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Adnani, Manav Nandwani, and Kishore Nandwani serve as directors at the Company.
- CIN/LLPIN
U24211MP2014PTC033401
- Company No.
033401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zorg Life Sciences (India) Private Limited offer?
Zorg Life Sciences (India) Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Anti Infective Drugs & Medicines, Antibiotic Injection, Cardiac Drugs, Antibacterial Drugs, Ayurvedic,Herbal Products & Medicine, Herbal Capsules.
Who are the key members and board of directors at Zorg Life Sciences (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Adnani  | Additional Director | 17-Aug-2022 | Current |
| Manav Nandwani | Director | 10-Nov-2014 | Current |
| Kishore Nandwani | Director | 10-Nov-2014 | Current |
Financial Performance of Zorg Life Sciences (India).
Zorg Life Sciences (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 111.56% increase. The company also saw a substantial improvement in profitability, with a 29.14% increase in profit. The company's net worth Soared by an impressive increase of 112.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zorg Life Sciences (India)?
In 2021, Zorg Life Sciences (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zorg Life Sciences (India)?
Unlock and access historical data on people associated with Zorg Life Sciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zorg Life Sciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zorg Life Sciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
